- Home
- CALX vs RCKT Comparison
CALX vs RCKT Comparison
Compare CALX & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALX
- RCKT
- Stock Information
- Founded
- CALX 1999
- RCKT 1999
- Country
- CALX United States
- RCKT United States
- Employees
- CALX N/A
- RCKT N/A
- Industry
- CALX Telecommunications Equipment
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- CALX Consumer Discretionary
- RCKT Health Care
- Exchange
- CALX Nasdaq
- RCKT Nasdaq
- Market Cap
- CALX 2.4B
- RCKT 1.9B
- IPO Year
- CALX 2010
- RCKT N/A
- Fundamental
- Price
- CALX $37.11
- RCKT $17.13
- Analyst Decision
- CALX Strong Buy
- RCKT Strong Buy
- Analyst Count
- CALX 6
- RCKT 9
- Target Price
- CALX $42.50
- RCKT $53.22
- AVG Volume (30 Days)
- CALX 368.7K
- RCKT 731.3K
- Earning Date
- CALX 10-28-2024
- RCKT 11-04-2024
- Dividend Yield
- CALX N/A
- RCKT N/A
- EPS Growth
- CALX N/A
- RCKT N/A
- EPS
- CALX N/A
- RCKT N/A
- Revenue
- CALX $890,128,000.00
- RCKT N/A
- Revenue This Year
- CALX N/A
- RCKT N/A
- Revenue Next Year
- CALX $4.01
- RCKT $300.20
- P/E Ratio
- CALX N/A
- RCKT N/A
- Revenue Growth
- CALX N/A
- RCKT N/A
- 52 Week Low
- CALX $26.76
- RCKT $15.98
- 52 Week High
- CALX $45.15
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- CALX 50.00
- RCKT 46.41
- Support Level
- CALX $36.89
- RCKT $17.05
- Resistance Level
- CALX $40.41
- RCKT $17.75
- Average True Range (ATR)
- CALX 1.16
- RCKT 0.72
- MACD
- CALX -0.08
- RCKT 0.06
- Stochastic Oscillator
- CALX 34.89
- RCKT 40.23
About CALX Calix Inc
Calix Inc develops, market and sell Calix cloud, systems and software platforms to enable service providers of all types and sizes to innovate and transform. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.